RF
GILD icon

Rossby Financial’s Gilead Sciences GILD Stock Holding History

Rossby Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164K Sell
1,298
-303
-19% -$39.9K 0.03% 434
2026
Q1 		$225K Buy
1,601
+675
+73% +$94.5K 0.05% 354
2025
Q4 		$114K Buy
926
+101
+12% +$12.3K 0.04% 382
2025
Q3 		$91.7K Buy
825
+7
+0.9% +$796 0.03% 413
2025
Q2 		$90.7K Buy
818
+146
+22% +$15.5K 0.03% 383
2025
Q1 		$69.3K Sell
672
-1,839
-73% -$190K 0.03% 409
2024
Q4 		$232K Buy
+2,511
New +$226K 0.14% 162

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rossby Financial's GILD Position: Q2 2026 in Review

Rossby Financial reduced its Gilead Sciences (GILD) stake by 19% in Q2 2026, selling an estimated $39.9K and leaving 1,298 shares worth $164K. The position accounts for 0.03% of the portfolio, ranked #434.

Rossby Financial first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $232K in Q4 2024. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Rossby Financial held 1,298 shares of Gilead Sciences worth $164K as of Q2 2026.
  • Rossby Financial sold 303 Gilead Sciences shares in Q2 2026, an estimated $39.9K.
  • Gilead Sciences made up 0.03% of Rossby Financial's portfolio in Q2 2026, its #434 holding.
  • Rossby Financial first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Rossby Financial's Gilead Sciences position peaked at $232K in Q4 2024.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.